Skip to main content

Glycoproteins and Glycosylation: Apolipoprotein C3 Glycoforms by Top-Down MALDI-TOF Mass Spectrometry

  • Protocol
  • First Online:
Liver Proteomics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 909))

Abstract

Apolipoprotein C3 (ApoC3) is synthesized in liver so that levels or isoform distributions may constitute indicators of liver pathogenesis. The glycoforms of intact protein ApoC3 in serum or plasma can be readily analyzed by matrix-assisted laser desorption/ionization-time of flight mass spectrometry after a one-step extraction using a C4 reverse-phase ZipTip. Glycoform distributions were sensitive to severe systemic diseases such as sepsis or liver diseases such as chronic hepatitis C and alcoholic liver cirrhosis. Glycoisoform distributions were also altered in persons with elevated body mass index and were corrected to normal distribution by metformin, a common drug used for diabetes therapy. This simple method may offer an approach to analysis of health and the mechanism of drug therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kirmiz C, Li B, An HJ, Clowers BH, Chew HK, Lam KS, Ferrige A, Alecio R, Borowsky AD, Sulaimon S, Lebrilla CB, Miyamoto S (2007) A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics 6:43–55

    PubMed  CAS  Google Scholar 

  2. Kyselova Z, Mechref Y, Al Bataineh MM, Dobrolecki LE, Hickey RJ, Vinson J, Sweeney CJ, Novotny MV (2007) Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res 6:1822–1832

    Article  PubMed  CAS  Google Scholar 

  3. Qiu Y, Patwa TH, Xu L, Shedden K, Misek DE, Tuck M, Jin G, Ruffin MT, Turgeon DK, Synal S, Bresalier R, Marcon N, Brenner DE, Lubman DM (2008) Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res 7:1693–1703

    Article  PubMed  CAS  Google Scholar 

  4. Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H (2009) Alteration of protein glycosylation in liver diseases. J Hepatol 50:592–603

    Article  PubMed  CAS  Google Scholar 

  5. Harvey SB, Zhang Y, Wilson-Grady J, Monkkonen T, Nelsestuen GL, Kasthuri RS, Verneris MR, Lund TC, Ely EW, Bernard GR, Zeisler H, Homoncik M, Jilma B, Swan T, Kellogg TA (2009) O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease. J Proteome Res 8:603–612

    Article  PubMed  CAS  Google Scholar 

  6. Ceciliani F, Pocacqua V (2007) The acute phase protein alpha1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci 8:91–108

    Article  PubMed  CAS  Google Scholar 

  7. Durand G, Seta N (2000) Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. Clin Chem 46:795–805

    PubMed  CAS  Google Scholar 

  8. Turnbull JE, Field RA (2007) Emerging ­glycomics technologies. Nat Chem Biol 3:74–77

    Article  PubMed  CAS  Google Scholar 

  9. Siuti N, Kelleher NL (2007) Decoding protein modifications using top-down mass spectrometry. Nat Methods 4:817–821

    Article  PubMed  CAS  Google Scholar 

  10. Nelsestuen GL, Zhang Y, Martinez MB, Key NS, Jilma B, Verneris M, Sinaiko A, Kasthuri RS (2005) Plasma protein profiling: unique and stable features of individuals. Proteomics 5:4012–4024

    Article  PubMed  CAS  Google Scholar 

  11. Zhang Y, Oetting WS, Harvey SB, Stone MD, Monkkonen T, Matas AJ, Cosio FG, Nelsestuen GL (2009) Urinary Peptide patterns in native kidneys and kidney allografts. Transplantation 87:1807–1813

    Article  PubMed  CAS  Google Scholar 

  12. Akkina SK, Zhang Y, Nelsestuen GL, Oetting WS, Ibrahlm HN (2009) Temporal stability of the urinary proteome after kidney transplant: more sensitive than protein composition? J Proteome Res 8:94–103

    Article  PubMed  CAS  Google Scholar 

  13. Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH (2005) Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 5:1705–1713

    Article  PubMed  CAS  Google Scholar 

  14. Zhang Y, Wroblewski M, Hertz MI, Wendt CH, Cervenka TM, Nelsestuen GL (2006) Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics 6:1001–1010

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gary L. Nelsestuen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this protocol

Cite this protocol

Zhang, Y., Sinaiko, A.R., Nelsestuen, G.L. (2012). Glycoproteins and Glycosylation: Apolipoprotein C3 Glycoforms by Top-Down MALDI-TOF Mass Spectrometry. In: Josic, D., Hixson, D. (eds) Liver Proteomics. Methods in Molecular Biology, vol 909. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-959-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-959-4_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-958-7

  • Online ISBN: 978-1-61779-959-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics